In a rat model of IBS, enhanced expression of a T-type channel, Cav3.2, coincided with development of hypersensitivity to colorectal distension, proposing this VGCC as a potential target for the treatment of IBS-associated chronic pain [143]. This evidence concerns the gene CACNA1H and irritable bowel syndrome.